Effects of Proxelan Somministration in Patients With Chronic Prostatitis
Unknown statusPhase 3NCT03629769
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of the study is to determinate the antinflammatory effects of the Proxelan on a cohort of patients affected by prostatitis'like symptoms and clinical evidence of abacterical prostatistis, trough a significative improvements of pain symptoms according to the NIH-CPSI questionnaire items, spermatozoa motility/concentration variations and the semen cytokines level decrease.
Study details
- Official title
- Effects of Proxelan Somministration in Patients With Chronic Prostatitis Cat. IIa NIH: Pilot Study
- Conditions
- Chronic Prostatitis
- Chronic Prostatitis With Chronic Pelvic Pain Syndrome
- Premature Ejaculation
- Interventions
- Drug: Proxelan
- Sponsor
- University of Pisa
- Start date
- 2017-02-16
- Primary completion
- 2018-09-01
- Sex
- Male
- Age range
- from 18 Years to 50 Years
- Results posted
- No results posted in this snapshot
- Countries
- Italy
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: \- prostatitis like symptoms for at least three months Exclusion Criteria: * significant post-voidal residual volume * Meares and Stamey test suggestive for bacterial infection * neoplasms, * urinary stones, * antibiotic therapy in the previous three months, * irritable bowel syndrome, * previous radiotherapic or chemiotherapic treatment, * urethral stenosis, * neurogenic bladder * previous prostatic surgery
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03629769